Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

https://www.soho2019.com/

Hodgkin Lymphoma
Multiple Myeloma
Chronic Lymphocytic Leukemia
Meet The Professor Sessions
Chronic Myeloid Leukemia
Myeloproliferative Neoplasms
Breakfast With The Expert
Independent Satellite Symposium
Plenary Sessions
Evolving Practices in AML: A Case-based Guide to New and Emerging Treatment Options
Acute Lymphoblastic Leukemia
Myelodysplastic Syndromes
Acute Myeloid Leukemia
Indolent B-cell Lymphoma
Mantle Cell Lymphoma
Aggressive B-cell Lymphoma
T-cell Lymphoma
Cellular Therapy
Next Questions
Events

Playback speed

10 seconds

How To Cure The Very High Risk Childhood ALL? Dasatinib vs. Imatinib & Combination Venetoclax and Navitoclax in R/R

By Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019) FEATURING Ching-Hon Pui

13 views

October 16, 2019

Comments 0

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal

Moving Forward in Stage III/IV Classical Hodgkin Lymphoma

Feat. A. Ip

Meet The Professor Sessions

New Kinase Inhibitors for CML: Asciminib, PF-114, & HQP1351

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

M. Mauro

29 views

Biomarkers To Predict Treatment Free Remission in CML – Can We Predi…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

T. Hughes

166 views

Management of Advanced Phase CML: Treatment Options for Accelerated,…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

E. Jabbour

26 views

Where do Immunotherapies Fit in the Treatment Landscape of ALL?

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

P. Kebriaei

73 views

How To Cure The Very High Risk Childhood ALL? Dasatinib vs. Imatinib…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

C. Pui

13 views

The Future of Frontline ALL in Adults: Complex Biological Work up an…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

N. Boissel

21 views

Harnessing the Immune System for Treating AML: Targeting CD33 and IL…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

F. Ravandi

122 views

IDH Inhibitor Therapy in AML: Ivosidenib & Enasidenib Mono and Combi…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

C. DiNardo

341 views

Manipulating Microenvironment to Overcome Chemotherapy Resistance in…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

D. DeAngelo

17 views

Identification and Management of Patients with Polycythemia Vera and…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

S. Verstovsek

37 views

Combination Approaches With Ruxolitinib in Primary Myelofibrosis - W…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

N. Pemmaraju

22 views

Identification and Management of Ruxolitinib Failure in Myelofibrosi…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

L. Masarova

62 views

Double-Hit Lymphoma Diagnosis, Initial and Relapsed/Refractory Treat…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

K. Dunleavy

118 views

The Role of Venetoclax in DLBCL: Efficacy and Safety Results from th…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

A. Zelenetz

90 views

Treating Elderly Patients with Hodgkin Lymphoma - How Much Bleomycin…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

A. Moskowitz

184 views

From CHIP, ICUS, and CCUS to Myelodysplastic Syndromes: Disease Stat…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

L. Godley

35 views

Lower Risk Myelodysplastic Syndromes Management: Overview of the Cur…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

R. Komrokji

35 views

Higher Risk Myelodysplastic Syndromes Management: Overview of the Cu…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

V. Santini

26 views

Induction Therapy for Myeloma in 2019 and Beyond: Is MRD Our Goal an…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

A. Krishnan

147 views

Discrepancy Between Real World vs. Clinical Trial Data in Relapsed/R…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

M. Dimopoulos

406 views

Epigenetic Mechanisms in CLL: Inter- and Intra-Patient Heterogeneity…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

D. Rossi

18 views

Mechanisms of Resistance in CLL to Targeted Agents: Could We Use The…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

P. Ghia

68 views

Genomic Complexity of CLL: Complex Karyotype, Cytogenetic Complexity…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

R. Brandell

26 views